ISO 13485:2016 QMS recertification
The Electrospinning Company has updated its Quality Management System to the new ISO 13485:2016 standard for the design, development, manufacture and supply of electrospun polymer scaffolds, and has been re-certified for a further three years. The ISO13485 standard has been updated from 13485:2003 to 13485:2016 to keep up with changes in the medical device industry… Read more »
Biotrinity – London – April 24th 2018
BioTrinity is Europe’s Leading Biopartnering and Investment Conference and is in London from April 23-25 2018 Ann Kramer will be on a panel ‘The Future of Medical 3D Printing’ session at BioTrinity 2018, that is taking place on Tuesday, 24 April at 13:40 – 14:30.
Electrospinning for drug delivery – London – 18th April 2018
The UK-China Mini-Symposium on Electrospinning for Drug Delivery will bring together researchers from both the UK and China to discuss the latest developments in this exciting and rapidly evolving field of pharmaceutical technology. It will take place in UCL’s School of Pharmacy in the heart of London. Keynote speakers: Prof Limin Zhu, Donghua University Prof… Read more »
ELRIG research and Innovation – Cambridge, UK – 17-18 April 2018
We will be at ELRIG Research and Innovation 2018 at Homerton College, Cambridge, UK on 17-18th April. Stephen Jones will present a poster on aligned fibre scaffolds for 3D cell culture.
Materials Research Exchange – London – 13th March 2018
Ann Kramer will be at The Materials Research Exchange event at the Design Centre, Islington, London on 13th March. The 2018 Materials Research Exchange Conference and Exhibition will showcase the richness of UK materials research and innovation providing an ideal opportunity to absorb current trends and take a glimpse of future innovations.
AAOS – New Orleans – March 6-10, 2018
Marco Thio will attend the American Academy of Orthopaedic Surgeons (AAOS) 2018 Annual Meeting from March 6-10th in New Orleans, USA. Please contact us if you would like to discuss the use of biomaterials / electrospun scaffolds in orthopaedic devices.
Future Healthcare – London – 13/14 March 2018
Marco Thio will be at The Future Healthcare Exhibition and Conference on 13th and 14th March.
Biomaterials Risk Management BIORIMA H2020 grant
The Electrospinning Company is a partner in the EU funded H2020 Research and Innovation action BIORIMA (Biomaterial Risk Management). The project aims to develop an integrated risk management framework for nano-biomaterials used in advanced therapeutic medicinal products and medical devices. The BIORIMA risk management framework is a structure upon which the validated tools and methods… Read more »
MeDe Innovation – Sheffield, UK – 18 Jan 2018
Marco Thio will be at the MeDe Innovation 5th Annual Conference. The conference brings together MeDe Innovation’s network of academics, industrialists, clinicians and regulatory body representatives through lively presentations, debate and poster sessions. It is a unique opportunity to access the latest developments in orthopaedic medical device manufacture. Selina Beal (@SN_Beal) from the University of… Read more »
BioBeat BioBusiness 2017
Ann Kramer, CEO of The Electrospinning Company is named as one of 50 female leaders in healthcare business in the UK in a report produced by BioBeat, 50 Movers and Shakers in BioBusiness 2017 , which emphasises how diversity of thinking is critical to the success of the sector in the UK. The 50 Movers and… Read more »
Stem cell culture in coated scaffolds
A simple 3-D culture system, made of electrospun polycaprolactone (PCL) fibers and coated with defined extracellular proteins that occur naturally in the stem cell niche, allowed dispersed attachment and culture of human pluripotent stem cells devoid of cell aggregation. A publication from The Royal Institute of Technology (KTH), Stockholm describes how PCL fiber scaffolds coated… Read more »
Stewart White appointed NED
The Electrospinning Company has strengthened its Board with the appointment of Dr Stewart White as non-executive director. Stewart was previously CEO of two life science AIM-quoted companies including Collagen Solutions Ltd., and is currently Chairman of Mikota Ltd and non-executive director with Taragenyx. Stewart has international executive experience in commercial and product development, GMP manufacturing of… Read more »
